Skip to content

Strength Training Study for Survivors of Breast and Gynecologic Cancer

The Effect of Resistance Exercise Frequency in Breast and Gynecologic Cancer Survivors

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01709175
Enrollment
20
Registered
2012-10-18
Start date
2012-11-30
Completion date
2015-01-31
Last updated
2015-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Cervical Cancer, Gynecologic Cancer, Ovarian Cancer, Uterine Cancer

Keywords

Cancer, Breast Cancer, Gynecologic Cancer, Strength Training, Exercise, Physical Activity, Fatigue, Quality of Life, Strength, Fitness, Cancer Survivor, Survivor

Brief summary

The purpose of this study is to compare once-a-week vs. twice-a-week strength training in survivors of breast and gynecologic cancer to determine which is the optimal exercise prescription.

Detailed description

As a result of cancer and its treatment, survivors of breast and gynecologic cancer are reported to have deficits in both physical and psycho-social health. In cancer survivors exercise has been shown to improve fitness, increase bone density and lean body mass, enhance self-esteem, and reduce fatigue. These changes have a positive effect on the survivor's physical functioning and quality of life. However, there are few studies which have examined the effects of strength training or studies aimed at determining optimal exercise prescription in this population. Therefore, the purpose of this study is to compare two strength training prescriptions (once-a-week vs. twice-a-week strength training) to determine which prescription (if any) results in greater benefit for survivors. It is hoped that the results of this study will lead to a better understanding of how strength training improves the health of survivors and will help inform future exercise guidelines for this population.

Interventions

BEHAVIORALStrength Training

This is a 13 week strength training program. Sessions will be supervised by a Certified Exercise Physiologist in a group setting.

Sponsors

Dalhousie University
CollaboratorOTHER
Nova Scotia Health Authority
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Female Survivor of Breast or Gynecologic Cancer * Completed Primary Treatment (hormone treatments are ok) * 18 years of age or older * Physician's Permission to Participate

Exclusion criteria

* High Risk Individuals (determined by questionnaire) * Secondary Health Problems that could increase the risk of participating (Includes but not limited to: Uncontrolled angina/hypertension, heart failure, osteoporosis, brain metastases, history of seizures). * Report participating in a strength training program in the past six (6) months * Have had a change in medication in the past 30 days

Design outcomes

Primary

MeasureTime frameDescription
Changes in Muscular StrengthBaseline (end of week 1); Midpoint (end of week 7); Final (end of week 13)Muscular Strength will be assessed using the predicted one-repetition maximum method (Brzycki method)using the bench press and leg press to measure upper and lower body strength.

Secondary

MeasureTime frameDescription
Process MeasuresFinal (end of week 13)Process measures will provide insight about the feasibility of the exercise prescriptions. Included measures are: recruitment (percent of interested survivors who consent); adherence (the number of sessions attended); compliance (the degree to which the survivors follow the exercise prescription); and safety (all adverse events will be recorded)
Changes in Muscular EnduranceBaseline (end of week 1); Midpoint (end of week 7); Final (end of week 13)Muscular Endurance will be assessed using the standard load test. Participants will lift a weight equal to 50% one repetition maximum as many times as possible. The bench press and leg press will be used to measure endurance of the upper and lower body.
Changes in Body CompositionBaseline (end of week 1); Midpoint (end of week 7); Final (end of week 13)Body composition will be assessed using bioelectric impedance to determine percent body fat, lean body mass, and fat mass.
Changes in Quality of LifeBaseline (end of week 1); Midpoint (end of week 7); Final (end of week 13)Quality of Life will be assessed using the Medical Outcomes Survey - Short Form. This survey measures multiple aspects of quality of life including: physical function, role-physical, bodily-pain, general health, vitality, social functioning, role-emotional, and mental health.
Changes in FatigueBaseline (end of week 1); Midpoint (end of week 7); Final (end of week 13)Fatigue will me measured using the Fatigue scale of the Functional Assessment of Cancer Treatment. This is a 13 item questionnaire that measures the degree to which a cancer survivor experiences fatigue
Changes in Physical Activity LevelsBaseline (end of week 1); Midpoint (end of week 7); Final (end of week 13)Physical activity will be estimated using the Godin Leisure Time Exercise Questionnaire.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026